Acute tumor lysis syndrome secondary to hydroxyurea in acute myeloid leukemia

Annals of Pharmacotherapy

Volumn 37, Issue 5, 2003, Pages 675-678

  Seki, Jack T ^a   Al Omar, Hamad M ^b   Amato, Dominick ^c   Sutton, David M C ^b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Acute renal failure; Acute tumor lysis; Hydroxyurea; Leukemia

Indexed keywords

ALLOPURINOL; CHLORAMBUCIL; CREATININE; ELECTROLYTE; HYDROXYUREA; POLYSTYRENESULFONATE SODIUM;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE KIDNEY FAILURE; AGED; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TUMOR LYSIS SYNDROME;

AGED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; HYDROXYUREA; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MALE; TUMOR LYSIS SYNDROME;

EID: 0037407545     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C188     Document Type: Article

References (21)

1. Chasty RC, Liu-Yin JA. Acute tumor lysis syndrome. Br J Hosp Med 1993;49:488-92.
2. Cohen LF, Balow IE, Magrath IT, Poplack DG, Ziegler JL. Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma. Am J Med 1980;68:486-91.
3. Cadman EC, Lunberg WB, Bertino JR. Hyperphosphatemia and hypocalcemia accompanying rapid cell lysis in a patient with Burkitt's lymphoma and Burkitt cell leukemia. Am J Med 1977;62:283-90.
4. Kedar A, Grow W, Neiberger RE. Clinical versus laboratory tumor lysis syndrome in children with acute leukemia. Pediatr Hematol Oncol 1995;12:129-34.
5. Razis E, Arlin ZA, Ahmed T, Feldman EJ, Puccio C, Cook P, et al. Incidence and treatment of tumor lysis syndrome in patients with acute leukemia. Acta Haematol 1994;91:171-4.
6. Tsokos GC, Balow JE, Spiegel RJ, Magrath IT. Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas. Medicine (Baltimore) 1981;60:218-29.
7. Zusman JI, Brown DM, Nesbit R. Hyperphosphatemia, hyperphosphaturia and hypocalcemia in acute lymphoblastic leukemia. N Engl J Med 1973;289:1335-40.
8. Altman A. Acute tumor lysis syndrome. Semin Oncol 2001;28(2 suppl 5):3-8.
9. Jeha S. Tumor lysis syndrome. Semin Hematol 2001;38(4 suppl 10):4-8.
10. Sullan S. Management of acute tumor lysis syndrome. Semin Oncol 2001;28(2 suppl 5):9-12.
11. Sinclair WK. Hydroxyurea: differential lethal effects on cultured mammalian cells during the cell cycle. Science 1965;150:1729-31.
12. Ettinger DS, Harker WG, Gerry HW, Sanders RC, Saral R. Hyperphosphatemia, hypocalcemia, and transient renal failure. Results of cytotoxic treatment of acute lymphoblastic leukemia. JAMA 1978;239:2472-4.
13. Donehower RC. Hydroxyurea. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy. Principles and practice. 2nd ed. Philadelphia: Lippincott-Raven, 1996:253-61.
14. Donehower RC. An overview of the clinical experience with hydroxyurea. Semin Oncol 1992;19(3 suppl 9):11-9.
15. Ford SS, Shackney SE. Lethal and sublethal effects of hydroxyurea in relation to drug concentration and duration of exposure in sarcoma 180 in vitro. Cancer Res 1977;37:2628-37.
16. Rodriguez GI, Kuhn JG, Weiss GR, Hilsenbeck SG, Eckardt JR, Thurman A, et al. A bioavailability and pharmacokinetic study of oral and intravenous hydroxyurea. Blood 1998;91:1533-41.
17. Moran RE, Straus MJ. Cytokinetic analysis of L1210 leukemia after continuous infusion of hydroxyurea in vivo. Cancer Res 1979;39:1616-22.
18. Tracewell WG, Trump DL, Vaughn WP, Smith DC, Gwilt PR. Population pharmacokinetics of hydroxyurea in cancer patients. Cancer Chemother Pharmacol 1995;35:417-22.
19. Lotfi M, Brandwein JM. Spontaneous acute tumor lysis syndrome in acute myeloid leukemia? A single case report with discussion of literature. Leuk Lymphoma 1998;29:625-8.
20. Duda J, Zoger S. Presentation of M4 acute myeloid leukemia in anuric renal failure with hyperuricemia and enlarged kidneys. J Pediatr Hematol Oncol 2002;24:55-8.
21. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.